Prenetics' IM8 partners with Authentic Brands Group on Care Bears wellness brand
The 10-year exclusive global deal will have IM8 operate a new Care Bears-branded vitamin line, with Authentic also becoming a strategic shareholder in Prenetics.
Prenetics Global Limited (NASDAQ: PRE) disclosed in a Form 6-K filed November 5, 2026 that its subsidiary IM8 entered a 10-year, exclusive, worldwide partnership with Authentic Brands Group to build Care Bears by IM8, a family health and wellness brand.1 IM8 will serve as the brand's exclusive operating partner, and Prenetics will record all revenue from Care Bears by IM8 and pay a royalty to Authentic.1
Care Bears by IM8 will debut with gummy multivitamins for both kids and adults, with a global launch targeted in the first half of 2027 as Care Bears celebrates its 45th anniversary.1 IM8 plans to expand the brand into better-for-you confectionery and wholesome kids' snacks and foods.1 It is the first wellness brand built on Care Bears, which Authentic acquired in August 2026 as its first character IP.1
As part of the agreement, Authentic will also become a strategic shareholder in Prenetics.1
On financial performance, the filing states that in the second quarter of 2026, IM8 generated $45 million in revenue, up approximately 359% year over year, and that in July 2026 IM8 recorded $20.9 million in monthly revenue, an annualized revenue run-rate of approximately $251 million about 20 months after launch.1 Prenetics raised its full-year 2026 revenue guidance to $220 million to $230 million and initiated 2027 IM8 revenue guidance of $400 million or more, which assumes no revenue from upcoming product launches.1 Neither the 2026 nor the 2027 guidance currently includes any contribution from Care Bears by IM8.1
Under the agreement terms, IM8 is the exclusive operating partner of Care Bears by IM8, with Prenetics recording all revenue and paying a royalty to Authentic, giving IM8 long-term, protected access to the IP without acquiring it, with no competing Care Bears wellness brand in any market.1
The filing also notes that it includes the License Agreement entered into by IM8 (US) LLC in connection with the partnership, filed as Exhibit 99.2, dated September 16, 2026.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.